J&J Settles Talc Suits for $5.5B as Amazon Scales Back AI Models

Johnson and Johnson announced it will pay an estimated 5.5 billion dollars to settle tens of thousands of claims that its talc based products including baby powder caused ovarian cancer. The agreement covers roughly 76,000 lawsuits consolidated in federal court in New Jersey and related state cases representing nearly all remaining talc claims against the company.

The deal requires approval from 95 percent of the ovarian cancer claimants before it becomes final. Plaintiffs law firms described the resolution as a positive outcome after years of litigation. J and J had already settled most cases alleging its talc contained asbestos and caused mesothelioma.

Company vice president of litigation Erik Haas called the claims meritless yet defended the settlement as a way to achieve closure. He stated the company would have prevailed in further litigation based on past trial results and emphasized the need to focus on developing medicines and devices. Payments are scheduled to begin with 3 billion dollars in 2027 and continue into 2028 with potential increases depending on participation.

The settlement comes after more than a decade of legal battles in which J and J repeatedly defended its talc products as safe. Critics have long argued that the company downplayed internal concerns about asbestos contamination in its talc supply. The agreement allows the corporation to move past the litigation without admitting liability while providing compensation to claimants who have pursued their cases through the courts.

Plaintiffs attorney Chris Seeger who represents about 2,500 clients and helped negotiate the deal noted the difficulty of obtaining justice against a large corporation. The payout underscores how prolonged court fights can pressure even well resourced companies to reach resolutions that avoid further public scrutiny of product safety records.

State and federal judges overseeing the cases will now review the terms to ensure broad acceptance among claimants. If the threshold is met the agreement could bring an end to one of the largest consumer product liability disputes in recent years. J and J maintains the settlement reflects a strategic choice rather than an acknowledgment of wrongdoing.

The resolution highlights ongoing questions about corporate accountability in cases involving widely used consumer goods and long term health effects. While the company insists its products posed no risk the scale of the payout indicates the legal and financial pressures that accumulated over ten years of litigation.